These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 27894776)
1. Design, synthesis, cyclooxygenase inhibition and biological evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing amino/methanesulfonyl pharmacophore. Abdellatif KR; Fadaly WA Bioorg Chem; 2017 Feb; 70():57-66. PubMed ID: 27894776 [TBL] [Abstract][Full Text] [Related]
2. Synthesis, cyclooxygenase inhibition and anti-inflammatory evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing methanesulphonyl pharmacophore. Abdellatif KR; Elsaady MT; Abdel-Aziz SA; Abusabaa AH J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1545-55. PubMed ID: 27072288 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1-phenylpyrazolo[3,4-d]pyrimidine derivatives. Bakr RB; Azouz AA; Abdellatif KR J Enzyme Inhib Med Chem; 2016; 31(sup2):6-12. PubMed ID: 27210522 [TBL] [Abstract][Full Text] [Related]
4. Discovery of new 2-(3-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)thiazole derivatives with potential analgesic and anti-inflammatory activities: In vitro, in vivo and in silico investigations. Mohammed ER; Abd-El-Fatah AH; Mohamed AR; Mahrouse MA; Mohammad MA Bioorg Chem; 2024 Jun; 147():107372. PubMed ID: 38653152 [TBL] [Abstract][Full Text] [Related]
5. COX-1/COX-2 inhibition assays and histopathological study of the new designed anti-inflammatory agent with a pyrazolopyrimidine core. Abdelall EKA; Lamie PF; Ahmed AKM; El-Nahass ES Bioorg Chem; 2019 May; 86():235-253. PubMed ID: 30716621 [TBL] [Abstract][Full Text] [Related]
6. Synthesis, Anti-Inflammatory Activity, and COX-1/2 Inhibition Profile of Some Novel Non-Acidic Polysubstituted Pyrazoles and Pyrano[2,3-c]pyrazoles. Faidallah HM; Rostom SAF Arch Pharm (Weinheim); 2017 May; 350(5):. PubMed ID: 28370254 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological evaluation and molecular modeling study of pyrazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents. Tewari AK; Singh VP; Yadav P; Gupta G; Singh A; Goel RK; Shinde P; Mohan CG Bioorg Chem; 2014 Oct; 56():8-15. PubMed ID: 24893208 [TBL] [Abstract][Full Text] [Related]
8. New 1,2-diaryl-4-substituted-benzylidene-5-4H-imidazolone derivatives: Design, synthesis and biological evaluation as potential anti-inflammatory and analgesic agents. Abdellatif KRA; Fadaly WAA Bioorg Chem; 2017 Jun; 72():123-129. PubMed ID: 28411407 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and anti-inflammatory evaluation of new 1,3,5-triaryl-4,5-dihydro-1H-pyrazole derivatives possessing an aminosulphonyl pharmacophore. Abdellatif KR; Abdelgawad MA; Elshemy HA; Alsayed SS; Kamel G Arch Pharm Res; 2015 Nov; 38(11):1932-42. PubMed ID: 25904239 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of some pyrazolo[3,4-d]pyrimidines as anti-inflammatory agents. Tageldin GN; Fahmy SM; Ashour HM; Khalil MA; Nassra RA; Labouta IM Bioorg Chem; 2018 Aug; 78():358-371. PubMed ID: 29627656 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, characterization and in vitro and in vivo anti-inflammatory evaluation of novel pyrazole-based chalcones. Chavan HV; Adsul LK; Kotmale AS; Dhakane VD; Thakare VN; Bandgar BP J Enzyme Inhib Med Chem; 2015 Feb; 30(1):22-31. PubMed ID: 24666306 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, cyclooxygenase inhibition, anti-inflammatory evaluation and ulcerogenic liability of new 1,5-diarylpyrazole derivatives. Abdellatif KR; Fadaly WA; Ali WA; Kamel GM J Enzyme Inhib Med Chem; 2016; 31(sup3):54-60. PubMed ID: 27541738 [TBL] [Abstract][Full Text] [Related]